For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
According to our (Global Info Research) latest study, the global Rhodiola Rosea P.E. market size was valued at USD 35 million in 2023 and is forecast to a readjusted size of USD 39 million by 2030 with a CAGR of 1.6% during review period.
Rhodiola rosea (commonly golden root, rose root, roseroot, western roseroot, Aaron's rod, Arctic root, king's crown, lignum rhodium, orpin rose) is a perennial flowering plant in the family Crassulaceae.
Rhodiola rosea P.E. is derived from the root and rhizome of Rhodiola rosea. It has been traditionally used as a rare Chinese medicinal herb, and it has also been applied in Tibetan medicine.
Since the 1970s, the natural stocks of rhodiola rosea are continuously diminishing as a result of unregulated collection. According to the Red List, the plant is severely endangered and even threatened by extinction. Rhodiola rosea has been on the list of the rare plants of Siberia since 1980 and the plant needs government protection.
In the face of declining availability of the natural supply, rhodiola rosea P.E. will continue in the state that production behind demand. And the price will continue to rise for some time.
At present, the major manufacturers of rhodiola rosea P.E. are Layn, Huisong Pharmaceuticals, Jinrui Natural Ingredients, Skyherb, Martin Bauer Group, etc. The top four companies occupied 27% of the total amount.
China is the dominate producer and exporter of rhodiola rosea P.E., with the production market share of 74%.
The Global Info Research report includes an overview of the development of the Rhodiola Rosea P.E. industry chain, the market status of Cosmetics (Rosavin, Salidroside), Health Care Products (Rosavin, Salidroside), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rhodiola Rosea P.E..
Regionally, the report analyzes the Rhodiola Rosea P.E. markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rhodiola Rosea P.E. market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rhodiola Rosea P.E. market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rhodiola Rosea P.E. industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., Rosavin, Salidroside).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rhodiola Rosea P.E. market.
Regional Analysis: The report involves examining the Rhodiola Rosea P.E. market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rhodiola Rosea P.E. market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rhodiola Rosea P.E.:
Company Analysis: Report covers individual Rhodiola Rosea P.E. manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rhodiola Rosea P.E. This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cosmetics, Health Care Products).
Technology Analysis: Report covers specific technologies relevant to Rhodiola Rosea P.E.. It assesses the current state, advancements, and potential future developments in Rhodiola Rosea P.E. areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rhodiola Rosea P.E. market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Rhodiola Rosea P.E. market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Rosavin
- Salidroside
Market segment by Application
- Cosmetics
- Health Care Products
- Pharmaceuticals
- Others
Major players covered
- Layn
- Martin Bauer Group
- Skyherb
- Acetar Bio-Tech
- Shaanxi Jintai
- Gansu Xinhuikang
- Bioland
- Jinrui Natural Ingredients
- Anhui Kunda Biological
- Wagott
- Huisong Pharmaceuticals
- Xi'an GreenMan
- Yuensun Biological Technology
- Xi'an Hao Tian
- Xi'an Gaoyuan
Market segment by region, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rhodiola Rosea P.E. product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rhodiola Rosea P.E., with price, sales, revenue and global market share of Rhodiola Rosea P.E. from 2019 to 2024.
Chapter 3, the Rhodiola Rosea P.E. competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rhodiola Rosea P.E. breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Rhodiola Rosea P.E. market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rhodiola Rosea P.E..
Chapter 14 and 15, to describe Rhodiola Rosea P.E. sales channel, distributors, customers, research findings and conclusion.